IGGRF yields 2.73% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, IGGRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IGGRF + JNJ for your $10,000?
IG Group Holdings plc engages in the online trading business worldwide. The company offers over-the-counter (OTC) leveraged derivatives, which include CFD (contracts for difference) that enable traders to take advantage of changes in an asset's price without owning the asset itself, as well as access to a range of risk-mitigation measures, including stops and limits, and negative-balance protection; and spread bets and options. It also provides exchange-traded derivatives under the tastytrade, an online brokerage and investor education platform; and Spectrum, a multilateral trading facility. In addition, the company offers stock trading services and investment services that include commodities, equities, and fixed-income assets. Further, it provides spread betting, CFD trading, foreign exchange trading, market risk management, data distribution, investment advisory, software development and support, financial, publication, exchange-traded funds trading, and translation services, as well as issues turbo warrants. The company was founded in 1974 and is headquartered in London, the United Kingdom.
Full IGGRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.